Low rates of monitoring of mood stabilizing drugs for bipolar disorder in community psychiatric clinics

dc.contributor.authorSchrader, G.
dc.contributor.authorAl Atrash-Najar, R.
dc.contributor.authorDhillon, R.
dc.contributor.authorBastiampillai, T.
dc.date.issued2002
dc.descriptionThe definitive version is available at www.blackwell-synergy.com
dc.description.statementofresponsibilityGeoffrey Schrader, Rima Al Atrash-Najar, Rohan Dhillon, Tarun Bastiampillai
dc.identifier.citationAustralian and New Zealand Journal of Psychiatry, 2002; 36(6):819-819
dc.identifier.doi10.1046/j.1440-1614.2002.t01-5-01101f.x
dc.identifier.issn0004-8674
dc.identifier.issn1440-1614
dc.identifier.orcidSchrader, G. [0000-0002-2504-8102]
dc.identifier.urihttp://hdl.handle.net/2440/33034
dc.language.isoen
dc.publisherBlackwell Publishing Asia
dc.source.urihttps://doi.org/10.1046/j.1440-1614.2002.t01-5-01101f.x
dc.subjectHumans
dc.subjectAntimanic Agents
dc.subjectDrug Monitoring
dc.subjectBipolar Disorder
dc.subjectCommunity Mental Health Centers
dc.titleLow rates of monitoring of mood stabilizing drugs for bipolar disorder in community psychiatric clinics
dc.typeJournal article
pubs.publication-statusPublished

Files